Co-diagnostics, inc. expands vector control customer base to 25 customers across 15 u.s. states

Salt lake city , july 2, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx™"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that use of the company's vector control technology will expand to the 15th u.s. state following an installation in nevada next week. co-dx vector control technology includes vector smart® pcr tests used in environmental (non-diagnostic) surveillance of mosquito pools for mosquito-borne illnesses like west nile virus, zika, dengue and chikungunya.
CODX Ratings Summary
CODX Quant Ranking